01 1Phlow Corporation
01 1EPINEPHRINE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-05-28
Pay. Date : 2025-04-10
DMF Number : 37581
Submission : 2024-12-16
Status : Active
Type : II
20
Phlow Corp, based in U.S.A, is a pharmaceutical company.
One of their notable products is EPINEPHRINE USP, with a corresponding US DMF Number 37581.
Remarkably, this DMF maintains an Active status since its submission on December 16, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 28, 2025, and payment made on April 10, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
